Registration Now Open for 4th Annual Medical Device Regulatory Clearance & Approval Conference
08/21/2014

Regulatory Approvals in China, 510(k) Guidance Among This Years’ Discussion Topics

Online PR News – 21-August-2014 – Chicago, IL – For the fourth straight year, Q1 Productions will host the annual Medical Device Regulatory Clearance and Approval Conference, offering regulatory affairs professionals exclusive insight to the latest trends and newest happenings within the industry. The conference will take place November 3-4, 2014 in Arlington, Virginia.

This year, a variety of new session topics will be on the agenda addressing several hot topics, including 510(k) guidances, regulations for product approval in China, updates on the European directives, and gaining approval of mobile medical applications. Among the nearly two dozen legal and industry speakers set to present are Mark Duval of Duval & Associates, Herbert Lerner of the FDA, Gemma Moore of Edwards Lifesciences, and Robert Steele of Stryker.

As medical device manufacturers seek to gain clearance and approval for products in other countries, sessions at this conference will focus on culture communication with distributors and foreign agencies. Attendees will have the opportunity to network and discuss the 2014 revision of the Chinese medical device regulations and gain exclusive insight to the challenges of navigating new Chinese clearance and approval processes including clinical trials, labeling requirements and CFDA communication and processing timelines.

For more information or to register for the 4th Annual Medical Device Regulatory Clearance and Approval Conference, please visit www.q1productions.com/deviceregulation/. You can also follow Q1 Productions on Twitter @Q1productions, #q1MDRC.

About the Organizer
Q1 Productions designs and develops webinars, training courses, conference programs and forums aimed at specifically targeted audiences throughout highly regulated industries in order to provide strategic learning and timely program content. Through a highly structured production process focused on research calls with end-users and key stakeholders in the industry, our team is able to understand the immediate business concerns of today’s leading executives. Whether focusing on new or pending legislative and health policy issues or enhanced technologies or processes that will drive efficiency, our programs provide solutions to the urgent educational and information needs of our attendees.